The End of Buying the Box
For decades, MedTech commercial success followed a familiar pattern: sell the capital equipment, secure the consumables, add a service contract and move on to the next opportunity. The device sat at the centre of the relationship, with the services surrounding it often treated as separate additions.
That model is changing. Healthcare providers are facing tighter budgets while technology continues to evolve rapidly, making substantial upfront investments more difficult to justify when today’s innovation could appear outdated within a relatively short period. Leasing, subscriptions, managed services and pay-per-use arrangements are therefore becoming part of the buying conversation. Suppliers are also bringing together hardware, software, training, maintenance, analytics and upgrades into a more connected proposition. While this may initially look like a different way of pricing the same product, the implications go much further.
More Than a Pricing Change
The more significant shift is in where risk sits within the relationship. Under the traditional model, much of that risk passed to the customer once the device had been purchased. With a service-based model, the supplier remains responsible for demonstrating value throughout the relationship. Delivering the equipment is only the beginning; the device needs to perform, the software must integrate, the training must work and the service must be reliable. Account teams need to respond when support is required, and the commercial arrangement must remain relevant as the customer’s circumstances change. When these elements are brought together in a longer-term agreement, value can no longer be assumed once the sale has been completed. It must be delivered and demonstrated over time.
A Different Buying Decision
This changes the nature of the decision facing the customer. The question is no longer simply, “Do we want to buy this device?” Increasingly, customers must also consider, “Do we want to rely on this company?”
That distinction is important because a longer-term agreement requires customers to assess the complete proposition, not just the technology in front of them. The performance of the device remains central, but responsiveness, service quality and flexibility carry greater weight when the relationship is expected to extend well beyond the original purchase order. Customers need confidence not only in the product, but also in the software, training, support and services that surround it.
For MedTech suppliers, this means that adding a subscription option to an existing price list will not be enough. Commercial models, supporting evidence, incentives and customer relationships all need to evolve alongside the offer. The challenge is not simply to introduce a different payment structure, but to build a proposition capable of delivering value across the customer lifecycle.
The Box Still Matters
None of this makes the physical device less important. Performance, quality and reliability remain fundamental. What has changed is the context in which the device is being considered. The box may still be the most visible part of the offer, but it increasingly sits within a broader decision involving software, service, training, maintenance, analytics and upgrades.
The end of buying the box is therefore not the end of the device. It signals a change in what customers are really buying and what suppliers must be prepared to provide. Commercial success will depend not only on selling a strong product, but on providing the responsiveness, reliability and flexibility needed to support customers throughout the relationship.